Literature DB >> 24659730

Synovial myxoma in the vertebral column of a dog: MRI description and surgical removal.

Casey P Neary1, William W Bush, Deena M Tiches, Amy C Durham, Patrick R Gavin.   

Abstract

A 12 yr old castrated male mixed-breed dog presented with a 2 wk history of progressive tetraparesis. Neurologic deficits included a short-strided choppy gait in the thoracic limbs and a long-strided proprioceptive ataxia in the pelvic limbs. Withdrawal reflexes were decreased bilaterally in the thoracic limbs. Signs were consistent with a myelopathy of the caudal cervical/cranial thoracic spinal cord (i.e., the sixth cervical [C] vertebra to the second thoracic [T] vertebra). A mass associated with the C6-C7 articular facet on the left side was identified on MRI of the cervical spinal cord. The lesion was hyperintense to spinal cord parenchyma on T2-weighted images, hypointense on T1-weighted images, and there was strong homogenous contrast enhancement. Significant spinal cord compression was associated with the lesion. The mass was removed through a C6-C7 dorsal laminectomy and facetectomy. Histopathology of the mass was consistent with a synovial myxoma of the articular facet. A postoperative MRI showed complete surgical resection. Albeit rare, synovial myxomas should be included in the list of differential diagnoses for neoplasms affecting the vertebral columns in dogs.

Entities:  

Mesh:

Year:  2014        PMID: 24659730     DOI: 10.5326/JAAHA-MS-5992

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  2 in total

1.  Magnetic Resonance Imaging Features of Extradural Spinal Neoplasia in 60 Dogs and Seven Cats.

Authors:  Mylène Auger; Silke Hecht; Cary M Springer
Journal:  Front Vet Sci       Date:  2021-01-07

2.  Diagnosis and radiation therapy of an extensive myxoma in the retropharyngeal region infiltrating the cranial cervical vertebral canal in a dog.

Authors:  David Schmid; Maximilian Körner; Carla Rohrer Bley
Journal:  Vet Radiol Ultrasound       Date:  2022-03-20       Impact factor: 1.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.